What is DSIP?

DSIP stands for Delta Sleep-Inducing Peptide. It is a naturally occurring nonapeptide, meaning it is made up of 9 amino acids. It was originally identified in sleep research for its connection with slow-wave sleep, also known as delta-wave sleep.

In research discussions, DSIP is commonly associated with sleep architecture, deep sleep quality, stress response, cortisol-related patterns, mood stability and the sleep-wake cycle. It is often discussed differently from traditional sedatives because the focus is on sleep regulation rather than simply forcing sedation.

DSIP Reconstitution Example

The example below is based on a common 10mg DSIP vial mixed with 3.0mL bacteriostatic water.

Standard / Gradual Research Protocol Example

This example uses a 10mg vial reconstituted with 3.0mL bacteriostatic water, giving an approximate concentration of 3.33mg/mL.

Frequency and Timing Notes

DSIP is commonly discussed as a once-daily evening compound in research-style protocols. The uploaded guide uses evening administration, approximately 30-60 minutes before bedtime, to align with sleep onset and natural nighttime sleep architecture.

Because the example amounts are small, the measured volume can be very low. For administrations around 10 units or less, a 30-unit or 50-unit insulin syringe may be easier to read than a larger 1mL syringe.

Reconstitution Steps

1. Confirm the vial size before calculating concentration.
2. Draw 3.0mL bacteriostatic water using sterile technique.
3. Inject the bacteriostatic water slowly down the inside wall of the vial.
4. Avoid blasting the powder directly and avoid creating foam.
5. Gently swirl or roll the vial until the powder is fully dissolved.
6. Do not shake aggressively.
7. Label the vial with the reconstitution date.
8. Store the reconstituted vial in the refrigerator at 2-8°C, protected from light.

Supplies Needed

The following example is based on an 8-12 week nightly research-style schedule using 10mg DSIP vials.

Protocol Overview

• Goal discussed in research: support sleep quality, slow-wave sleep and stress-response modulation.
• Schedule example: daily subcutaneous evening use for 8-12 weeks.
• Example amount range: 100-300mcg daily using gradual titration.
• Example reconstitution: 3.0mL bacteriostatic water per 10mg vial.
• Concentration: approximately 3.33mg/mL.
• Timing: commonly discussed 30-60 minutes before bedtime.
• Storage: lyophilised vials frozen or cool as directed, reconstituted vials refrigerated.

Example Dosing Protocol

• Start: 100mcg nightly.
• Progression: increase by around 50mcg every 1-2 weeks as tolerated in research-style examples.
• Target example: 250-300mcg nightly by weeks 4-8.
• Frequency: once daily in the evening.
• Timing: approximately 30-60 minutes before bedtime.
• Cycle length: 8-12 weeks, with a break commonly considered after the cycle.
• Site rotation: rotate injection sites to reduce local irritation.

How DSIP Works

DSIP is discussed as a neuromodulator of the sleep-wake cycle and stress response. Research references commonly connect DSIP with delta-wave or slow-wave sleep, which is the deeper stage of non-REM sleep.

DSIP is also discussed for its ability to cross the blood-brain barrier and influence central sleep-regulating pathways. Some research discussions also connect DSIP with inhibitory neuronal activity and modulation of sleep-related brain regions.

Another area of interest is the stress-response system. DSIP has been discussed for effects on ACTH and corticosterone release in stress models, suggesting possible involvement in hypothalamic-pituitary-adrenal axis regulation.

Potential Benefits Discussed in Research

• Sleep quality research
• Slow-wave or delta-wave sleep support
• Sleep architecture regulation
• Chronic insomnia research discussions
• Stress-response modulation
• HPA axis research
• Mood support discussions
• Reduced next-day grogginess compared with conventional sedative-style compounds in some discussions

Reported Side Effects and Limitations

DSIP is often discussed as having a relatively mild side-effect profile in research settings, but evidence is still limited and individual responses may vary.

• Occasional headache
• Occasional nausea
• Mild injection-site redness
• Itching or irritation around the injection site
• Variable sleep response between individuals
• Unknown long-term outcomes outside studied settings

Storage Instructions

• Lyophilised powder: store frozen at around -20°C, or cool, dry and protected from light as directed by the supplier.
• After reconstitution: refrigerate at 2-8°C.
• Avoid: heat, sunlight, repeated freeze-thaw cycles and leaving the vial at room temperature for extended periods.
• Aliquots: some protocols discuss preparing aliquots to reduce repeated vial handling and freeze-thaw exposure.
• Practical note: allow cold vials to reach room temperature before opening to reduce condensation exposure.

Injection Technique Notes

This section is general educational information only. It is not personal injection instruction.

• Use a new sterile insulin syringe for each administration.
• Clean the vial stopper and skin with alcohol and allow to dry.
• Common subcutaneous sites discussed include abdomen, thighs and upper arms.
• Rotate injection sites to reduce local irritation.
• Pinch a skinfold and insert into subcutaneous tissue at an appropriate angle.
• Do not aspirate for subcutaneous injections.
• Inject slowly and steadily.
• Wait a few seconds before withdrawing the needle.
• For smaller DSIP measurements, 30-unit or 50-unit insulin syringes may improve readability.
• Dispose of used sharps safely in a sharps container.

Lifestyle Factors That May Matter

• Consistent sleep schedule: going to sleep and waking at similar times supports circadian rhythm.
• Evening caffeine control: caffeine late in the day may interfere with sleep onset and depth.
• Screen exposure: reducing bright screens before bed may support natural sleep signalling.
• Sleep environment: a dark, cool room can support sleep quality and melatonin production.
• Stress management: high stress can disrupt sleep and may reduce the clarity of DSIP-related observations.
• Daytime movement: regular physical activity can support better nighttime sleep.

Use the Peptide Calculator

If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.

Where to Compare DSIP Suppliers

Peptide Hub Australia does not sell DSIP or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.

Frequently Asked Questions

How much BAC water do you add to a 10mg DSIP vial?

A common educational example is 3.0mL bacteriostatic water added to a 10mg vial, creating a concentration of approximately 3.33mg/mL.

How many units is 100mcg of DSIP?

If a 10mg vial is mixed with 3.0mL, 100mcg is approximately 3 units on a U-100 insulin syringe.

How many units is 200mcg of DSIP?

Using the same 10mg in 3.0mL example, 200mcg is approximately 6 units on a U-100 insulin syringe.

How many units is 300mcg of DSIP?

Using the same 10mg in 3.0mL example, 300mcg is approximately 9 units on a U-100 insulin syringe.

When is DSIP commonly discussed for timing?

DSIP is commonly discussed in evening protocols, around 30-60 minutes before bedtime.

Does DSIP cause next-day grogginess?

DSIP is often discussed as being different from conventional sedatives, but individual responses vary. Some people may still feel different the next day depending on dose, timing, sleep quality and other compounds used.

Is this a personal dosing recommendation?

No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.

Related Resources

• Peptide Calculator
• Compare Australian Peptide Vendors
• Compare Peptide Prices
• Package Audits